跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ROXIPIME POWDER FOR SOLUTION FOR INJECTION 2G/VIAL - HSA Drug Approval Details
Approvals
/
HSA
/
ROXIPIME POWDER FOR SOLUTION FOR INJECTION 2G/VIAL
Approved
THERAPEUTIC
ROXIPIME POWDER FOR SOLUTION FOR INJECTION 2G/VIAL
Pharma Vision San. Ve Tic. A.Ş. (TURKEY)Qilu Antibiotics Pharmaceutical Co., Ltd. (Blend-Cefepime Hydrochloride (Contains Arginine)) (CHINA)
🇸🇬 Health Sciences Authority
Approval Date
Feb 8, 2018
Approval ID
d2616e2dbd898da5
Company
Pharma Vision San. Ve Tic. A.Ş. (TURKEY)Qilu Antibiotics Pharmaceutical Co., Ltd. (Blend-Cefepime Hydrochloride (Contains Arginine)) (CHINA)
Type
Therapeutic
Approval Details
Approval Id
d2616e2dbd898da5
Drug Name
ROXIPIME POWDER FOR SOLUTION FOR INJECTION 2G/VIAL
Product Name
ROXIPIME POWDER FOR SOLUTION FOR INJECTION 2G/VIAL
Approval Number
SIN15420P
Approval Date
2018-02-08
Registrant
UNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route Of Administration
INTRAVENOUS
Atc Code
J01DE01
Atc Item Name
cefepime
Pharma Manufacturer Name
UNITED ITALIAN TRADING CORPORATION (PRIVATE) LIMITED
Active Ingredients
Cefepime hydrochloride 2.3784g eqv Cefepime
2g per vial
Cefepime hydrochloride 2.3784g eqv Cefepime
2g per vial
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Feb 8, 2018
Approval ID
d2616e2dbd898da5
Type
Therapeutic
Back to HSA Approvals